We are a German research-driven pharmaceutical company and it’s our goal to improve the lives of humans and animals worldwide. Country-specific content may have been issued in the countries where we do business. Follow us for news about healthcare topics, our research & development and company updates. This is a place where you can share your thoughts, and connect with other people. We are looking
forward to exchanging ideas and engaging in conversations! We want to ensure that this is a safe and informative environment and respectfully request that you follow our Community Guidelines:
• Be nice to each other, even if you disagree
• Be constructive and inspire further conversations
• Please do not provide diagnoses or treatment advice
• We don’t tolerate discriminatory or derogatory comments, hate speech, especially humiliation of people or groups of people
• We don’t tolerate threats and requests for violence against anyone or anything
• We don’t tolerate po*******hy, profanity, and other content that puts young people at risk
• Please don’t infringe on the applicable legislation (e. on data protection), copyrights or trademarks
• The comment function should not be misused as advertising space or for other off-topic subjects
• We don’t tolerate the promotion of illegal activities
You acknowledge that you, not Boehringer Ingelheim, are responsible for the contents of your submission. We reserve ourselves the right to delete or hide any content on our social media pages that violate the Community Guidelines.
